FLGT Fulgent Genetics RESULTS: Q2, Q2 operating expenses $61.752M, Q2 Operating Income $-36.073M, Q2 pretax profit $-29.69M, Q2 gross profit
FLGT Fulgent Genetics RESULTS: Q2, Q2 operating expenses $61.752M, Q2 Operating Income $-36.073M, Q2 pretax profit $-29.69M, Q2 gross profit $25.679M, Q2 REV $85.389M, Q2 ADJ EBITDA $-17.1M
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.